Loading
Septic Shock Point Prevalence / Sepsis · Observational Study
ClinicalTrials.gov · August 5, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed multicenter observational point-prevalence study conducted in Turkey between September 2025 and January 2026 to determine the prevalence of sepsis and septic shock in adult ICUs and evaluate 30-day mortality. No results have been posted in this registry record; only the protocol and study completion status are documented.
Observational. Septic Shock Point Prevalence, Sepsis; age from 18 Years. Intervention: Observational point-prevalence assessment; no intervention administered.. n = 850. 1 site: Turkey (Türkiye).
This is a completed multicenter observational point-prevalence study conducted in Turkey between September 2025 and January 2026 to determine the prevalence of sepsis and septic shock in adult ICUs and evaluate 30-day mortality. No results have been posted in this registry record; only the protocol and study completion status are documented.
Effect sizes, confidence intervals, p-values, and mortality rates are not available.
The source did not state who this applies to in practice.
This is a completed registry record for an observational point-prevalence study with no results posted; enrollment and design are documented but outcomes remain unreported.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07283588). This is a study registration, not published results. Lead sponsor: Gulhane Training and Research Hospital. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 850 participants (ACTUAL). Conditions: Septic Shock Point Prevalence, Sepsis. Primary outcome measures: Point-prevalence of sepsis and septic shock in adult ICU patients in Turkey , On the study day (two time points: September 2025 and January 2026). Brief summary: Sepsis is a life-threatening condition characterized by a dysregulated host response to infection, leading to tissue damage, multiple organ dysfunction (MODS), disseminated intravascular coagulation (DIC), and high mortality. Despite its global significance, robust epidemiological data from low- and middle-income countries, including Turkey, remain limited. This multicenter, two-timepoint point-prevalence study aims to determine the prevalence of sepsis and septic shock in adult intensive care units (ICUs) across Turkey and to evaluate associated clinical outcomes.The study will be conducted between September 2025 and January 2026 in adult ICUs nationwide. Sepsis and septic shock will be defined according to the 2021 Surviving Sepsis Campaign Guidelines. Detailed data will be collected on participating ICUs, clinicians, patient demographics, comorbidities, infection characteristics, organ dysfunction, laboratory findings, and treatments. Patients will be followed for 30 days to assess ICU length of stay, discharge status, mortality, and ventilator- and vasopressor-free days.The primary objective is to determine the point prevalence of sepsis and septic shock in Turkish ICUs. The secondary objective is to evaluate 30-day mortality among patients with sepsis and septic shock. The findings are expected to provide crucial epidemiological insights and help improve sepsis management strategies in Turkey.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.